ChemMedChem

Title Publication Date Language Citations
Expansion of a Synthesized Library of N‐Benzyl Sulfonamides Derived from an Indole Core to Target Pancreatic Cancer2023/07/20English
Identification of Balanol As a Potential Inhibitor of PAK1 That Induces Apoptosis and Cytoprotective Autophagy in Colorectal Cancer Cells2023/07/20English
Synthesis and Biological Activity of 2‐Benzo[b]thienyl and 2‐Bithienyl Amidino‐Substituted Benzothiazole and Benzimidazole Derivatives2023/07/24English
Exploring Covalent Bond Formation at Tyr‐82 for Inhibition of Ral GTPase Activation2023/07/06English
High‐Contrast and Fast‐Removable 19F‐MRI Labels with Perfluoro‐tert‐Butyl Substituents2023/07/17English
Collaboration is Key in 23!2022/12/27English
Exploration of the Binding Modes of Toll‐Like Receptor 4 Competitive Inhibitors: A Combined Ligand‐Based and Target‐Based Approach2023/01/31English
Front Cover: Hybrid Androgen Receptor Inhibitors Outperform Enzalutamide and EPI‐001 in in vitro Models of Prostate Cancer Drug Resistance (ChemMedChem 2/2023)2023/01/17English
Surface functionalized titanium nitride electrode for CMOS compatible bioelectronic devices2024/04/17English
Developing Low Molecular Weight PET and SPECT Imaging Agents2024/04/18English
Russell Mechanism‐Mediated Cancer Therapy: A Minireview2024/04/16English
Esterification of Cyclic N6‐threonylcarbamoyladenosine during RNA Sample Preparation2024/04/17English
N,N‐Diarysulfonamide reduces proinflammatory cytokine interleukin‐6 levels in cells through nuclear factor‐κB regulation2024/04/12English
Discovery and in vitro Evaluation of Novel Serotonin 5‐HT2A Receptor Ligands Identified Through Virtual Screening2024/04/15English
Chemists Invent Drugs and Drugs Save Lives**2024/04/14English
Rational Design and Synthesis of Isatin‐Chalcone Hybrids Integrated with 1H‐1,2,3‐Triazole: Anti‐proliferative Profiling and Molecular Docking Insights2024/04/18English
Front Cover: Challenges for the Discovery of Non‐Covalent WRN Helicase Inhibitors (ChemMedChem 8/2024)2024/04/16English
Recent Development of Transition Metal Complexes as Chemotherapeutic Hypoxia Activated Prodrug (HAP)2024/04/18English
Structure and Activity of Reconstructed Pseudo‐Ancestral Cyclotides2024/04/17English
Lysophosphatidic acid receptor 1 (LPA1) antagonists as potential migrastatics for triple negative breast cancer2024/04/22English
Exploring Raloxifene‐based Metallodrugs: A Versatile Vector Combined with Pt(II), Palladium(II) and Nickel(II) Dichlorides and Carborates against Triple‐Negative Breast Cancer2024/04/20English
Front Cover: Identification of ß‐Glucocerebrosidase Activators for Glucosylceramide hydrolysis (ChemMedChem 7/2024)2024/04/02English
Nucleic Acid Materials‐mediated Innate Immune Activation for Cancer Immunotherapy2024/04/15English
Accelerating BRPF1b hit identification with BioPhysical and Active Learning Screening (BioPALS)2024/03/01English
Investigating the Combined Toxicity of Cu(II) and Carbon Monoxide (CO); Cellular CO Delivery Using a Cu(II) Flavonolato Complex2024/03/13English
Stabilizing Pseudouridimycin: Synthesis, RNA Polymerase Inhibitory Activity, and Antibacterial Activity of Dipeptide‐Modified Analogues2023/10/06English
Lysyl Oxidases as Targets for Cancer Therapy and Diagnostic Imaging2023/09/04English
r‐BRICS – A Revised BRICS Module That Breaks Ring Structures and Carbon Chains2023/12/27English
Exploration of the Pharmacophore for Cytoskeletal Targeting Ruthenium Polypyridyl Complexes2023/08/29English
Screening Campaign and Docking Investigations in Identifying New Hit Compounds as Inhibitors of Human Carbonic Anhydrases Expressed In Tumour Cells2023/09/22English